CTMX
CytomX Therapeutics, Inc.After hours2.33−0.10 −3.93%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 2.34 +0.68%
Open
2.45
Prev close
2.42
Day range
2.322.45
52-week range
2.328.21
Volume
5.22M1.54×
Mkt cap
506.62M
P/E ttm
—
Fwd P/E
-4.94
EPS ttm
-0.5100
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−71.68%
CTMX earnings and estimates
CTMX Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
After the close · estimated
EPS consensus
$−0.07
range −0.11 – 0.03
EPS growth vs year ago
+21.4%
year ago −0.09
Revenue consensus
$10.45M
+75.3% vs year ago
Options-implied move
±32.3%
by Nov 20 · ATM straddle
Past 4 reactions
±15.3%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 AMC | −0.09 | −0.10 | +10.98% | $1.42M | +2.7% | −0.6% |
| Mar '26 | May 7, 2026 AMC | −0.10 | −0.11 | +13.04% | $10.26M | −0.5% | −5.5% |
| Dec '25 | Mar 16, 2026 BMO | −0.22 | −0.09 | −138.02% | $663.00K | +44.2% | −4.9% |
| Sep '25 | Nov 6, 2025 AMC | −0.09 | −0.04 | −114.95% | $5.96M | −13.6% | −7.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.07 | −0.110.03 | +21.4% | $10.45M | +75.3% | −0.07 0.0% | −0.11 +32.7% | 4 / 1 |
| Next quarter Dec 2026 | −0.10 | −0.12−0.06 | +53.8% | $5.33M | +704.4% | −0.10 +1.4% | −0.11 +7.9% | 3 / 3 |
| Current year Dec 2026 | −0.39 | −0.52−0.28 | −159.2% | $25.03M | −67.2% | −0.39 +0.4% | −0.42 +7.6% | 4 / 1 |
| Next year Dec 2027 | −0.47 | −0.67−0.16 | −21.0% | $25.34M | +1.2% | −0.47 +0.6% | −0.49 +3.2% | 4 / 3 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.09 | −0.11−0.08 | 3 | 0 / 0 |
| Dec 2026 | −0.10 | −0.12−0.09 | 3 | 0 / 0 |
| Mar 2027 | −0.11 | −0.13−0.08 | 3 | 0 / 0 |
| Jun 2027 | −0.12 | −0.15−0.08 | 3 | 0 / 0 |
| Sep 2027 | −0.15 | −0.18−0.11 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.40 | −0.43−0.37 | 4 | 0 / 0 |
| Dec 2027 | −0.52 | −0.67−0.39 | 4 | 0 / 0 |
| Dec 2028 | −0.60 | −0.73−0.47 | 2 | 0 / 0 |
| Dec 2029 | −0.53 | — | 1 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.